TY - JOUR AU - Guijarro, Luis G AU - Cano-Martínez, David AU - Toledo-Lobo, M Val AU - Salinas, Patricia Sanmartín AU - Chaparro, María AU - Gómez-Lahoz, Ana M AU - Zoullas, Sofía AU - Rodríguez-Torres, Rosa AU - Román, Irene D AU - Monasor, Laura Sebastián AU - Ruiz-Llorente, Lidia AU - Del Carmen Boyano-Adánez, María AU - Guerra, Iván AU - Iborra, Marisa AU - Cabriada, José Luis AU - Bujanda, Luis AU - Taxonera, Carlos AU - García-Sánchez, Valle AU - Marín-Jiménez, Ignacio AU - Acosta, Manuel Barreiro-de AU - Vera, Isabel AU - Martín-Arranz, María Dolores AU - Mesonero, Francisco AU - Sempere, Laura AU - Gomollón, Fernando AU - Hinojosa, Joaquín AU - Alvarez-Mon, Melchor AU - Gisbert, Javier P AU - Ortega, Miguel A AU - Hernández-Breijo, Borja AU - On Behalf Of The Predicrohn Study Group From Geteccu, PY - 2021 DO - 10.1016/j.biopha.2021.112239 UR - https://hdl.handle.net/10668/25733 T2 - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie AB - Inflammatory bowel diseases (IBD), represented by ulcerative colitis (UC) and Crohn's disease (CD), are characterized by chronic inflammation of the gastrointestinal tract, what leads to diarrhea, malnutrition, and weight loss. Depression of the... LA - en KW - Adalimumab KW - IGF-1 KW - Inflammatory bowel diseases KW - Adalimumab KW - Adult KW - Animals KW - Biomarkers KW - Body Weight KW - Colitis KW - Colitis, Ulcerative KW - Colon KW - Crohn Disease KW - Disease Models, Animal KW - Female KW - Humans KW - Insulin Receptor Substrate Proteins KW - Insulin-Like Growth Factor I KW - Intestinal Mucosa KW - Longitudinal Studies KW - Male KW - Middle Aged KW - Prospective Studies KW - Proto-Oncogene Proteins c-akt KW - Rats, Wistar KW - Signal Transduction KW - Spain KW - Time Factors KW - Treatment Outcome KW - Tumor Necrosis Factor Inhibitors TI - Relationship between IGF-1 and body weight in inflammatory bowel diseases: Cellular and molecular mechanisms involved. TY - research article VL - 144 ER -